GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

July 7, 2025

Study Completion Date

October 11, 2025

Conditions
Intraoperative BleedingLiver DiseasesGallbladder DiseasesHemorrhage, Surgical
Interventions
DEVICE

GATT-Patch

"GATT-Patch is a sterile, flexible and resorbable hemostatic sealing patch. It presents as a blue, soft, flexible, porcine gelatin fiber-based carrier impregnated with an NHS-POx / NU-POx granulate. GATT-Patch measures 10 cm long by 5 cm wide. GATT-Patch is active and can be applied on both sides. Blue color is an aid to visualize GATT-Patch when applied onto a bleeding location.~GATT-Patch is indicated for use as an adjunct to hemostasis in surgery for minimal, mild or moderate bleeding sites when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. GATT-Patch is intended to be used for management of hemorrhage during surgeries on the liver."

DEVICE

SURGICEL® Original

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is indicated for use in surgical procedures to assist in the control of capillary, venous and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

Trial Locations (6)

10065

Weill-Cornell, New York

28204

Atrium Health, Charlotte

63110

Washington University, St Louis

84111

Intermountain Healthcare, Murray

90033

University of Southern California, Los Angeles

08534

Capital Health, Pennington

Sponsors
All Listed Sponsors
lead

GATT Technologies BV

INDUSTRY